The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

GWP GW PHARMACEUTICALS PLC ORD 0.1P



Income Statement  (£ m) 30-Sep-11 30-Sep-12 30-Sep-13 30-Sep-14 30-Sep-15
Continuing Operations
Revenue  29.63 33.12 27.30 30.05 28.54
Operating Profit/(Loss)  2.27 1.04 -10.47 -19.64 -57.23
Net Interest  0.00 0.00 0.06 0.06 0.08
Profit Before Tax  2.53 1.24 -10.36 -19.57 -57.06
Profit After Tax  2.75 2.49 -4.55 -14.66 -44.56
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  2.75 2.49 -4.55 -14.66 -44.56
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  2.75 2.49 -4.55 -14.66 -44.56
 
Continuing EPS
Earnings per Share - Basic  2.10p 1.90p -3.00p -7.00p -18.10p
Earnings per Share - Diluted  2.00p 1.80p -3.00p -7.00p -18.10p
Earnings per Share - Adjusted  2.10p 1.90p -3.00p -7.00p -18.10p
Continuing and Discontinued EPS
Earnings per Share - Basic  2.10p 1.90p -3.00p -7.00p -18.10p
Earnings per Share - Diluted  2.00p 1.80p -3.00p -7.00p -18.10p
Earnings per Share - Adjusted  2.10p 1.90p -3.00p -7.00p -18.10p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 30-Sep-11 30-Sep-12 30-Sep-13 30-Sep-14 30-Sep-15
Assets
Non-Current Assets
Property, Plant & Equipment  1.87 2.43 4.31 5.15 12.06
Intangible Assets  5.21 5.21 5.21 5.21 5.46
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 2.06 6.77 17.10
  7.08 7.64 11.58 17.13 34.61
Current Assets
Inventories  1.42 3.54 4.66 4.78 4.76
Trade & Other Receivables  2.28 2.41 4.63 7.11 15.51
Cash at Bank & in Hand  28.32 29.34 38.07 164.49 234.87
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  32.02 35.28 47.36 176.38 255.14
 
Total Assets  39.10 42.92 58.94 193.50 289.75
 
Liabilities
Current Liabilities
Borrowings  -0.01 0.00 -0.10 -0.13 -0.11
Other Current Liabilities  -10.02 -11.56 -12.62 -17.20 -27.66
  -10.03 -11.56 -12.72 -17.33 -27.77
 
Net Current Assets  22.00 23.72 34.64 159.05 227.37
 
Non-Current Liabilities
Borrowings  0.00 0.00 -1.91 -1.78 -1.54
Provisions  0.00 0.00 0.00 0.00 0.00
Other Non-Current Liabilities  -11.42 -10.13 -8.92 -15.81 -15.17
  -11.42 -10.13 -10.82 -17.59 -16.71
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -21.45 -21.69 -23.54 -34.92 -44.48
 
Net Assets  17.65 21.23 35.40 158.58 245.27
 
Capital & Reserves
Share Capital  0.13 0.13 0.18 0.24 0.26
Share Premium Account  65.87 65.95 84.01 220.55 349.28
Other Reserves  20.18 20.18 20.18 19.26 19.19
Retained Earnings  -68.53 -65.03 -68.97 -81.46 -123.46
Shareholders Funds  17.65 21.23 35.40 158.58 245.27
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  17.65 21.23 35.40 158.58 245.27

Ratios - based on IFRS 30-Sep-11 30-Sep-12 30-Sep-13 30-Sep-14 30-Sep-15
Continuing Operations
PE Ratio - Adjusted  46.67 39.47 -29.00 -62.25 -27.57
PEG - Adjusted  -1.12 -4.15 n/a n/a n/a
Earnings per Share Growth - Adjusted  -41.67% -9.52% n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  22.50p 24.90p 18.02p 14.28p 11.58p
Pre-Tax Profit per Share  1.92p 0.93p -6.84p -9.30p -23.16p
Operating Margin  7.66% 3.15% -38.36% -65.37% -200.53%
Return on Capital Employed  20.33% 7.76% -31.97% -12.56% -23.60%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  9.35p 12.01p 17.01p 64.81p 91.82p
Net Gearing  -160.39% -138.16% -101.87% -102.52% -95.09%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address Porton Down Science Park, Salisbury, SP4 0JQ, United Kingdom
Company website http://www.gwpharm.com
Market cap(in millions)* £ 1,321.02
Listing/Admission to trading 28 Jun 2001
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
27-Jun-16
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 3,000
SEDOL 3054468
ISIN number GB0030544687


Start trading your favourite asset CFDs!
Carries risk of capital loss



GW PHARM. share fundamentals (GWP)